In agreement with our earlier observations, LISA-derived prediction showed that decreased DNA methylation in prostate cancer was associated with distinct chromatin remodeling enzymes, including BACH1 and PCGF6, in AA men (Additional File 2, Fig. S3B). This evidence concerns the gene BACH1 and prostate cancer.